{"url_path":"/register/2026-09-25/2026-19700","section_key":"summary","section_title":"Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-New Drug Application (NDA) 219694 for Atropine Sulfate Ophthalmic Solution, 0.01%","topic":"register","document":{"doc_type":"Notice","doc_date":"2026-09-25","source_url":"https://www.federalregister.gov/documents/2026/09/25/2026-19700/dermatologic-and-ophthalmic-drugs-advisory-committee-notice-of-meeting-establishment-of-a-public","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Health and Human Services Department"},"word_count":103,"has_tables":false,"body_markdown":null}